[Familial hypertriglyceridemia and diabetes mellitus type 2]

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Disorders

Background:

• Hypertriglyceridemia is a known cardiovascular risk factor in type-2 diabetes.
• Familial hypertriglyceridemia, a specific lipid disorder, can be associated with type-2 diabetes.
• The role of familial hypertriglyceridemia in the development of atherosclerosis in diabetic patients requires further clarification.

Purpose of the Study:

• To compare the prevalence of coronary insufficiency and carotid artery stenosis in type-2 diabetes patients with and without familial hypertriglyceridemia.
• To investigate the association between severe hypertriglyceridemia and symptomatic atherosclerosis in the context of type-2 diabetes.

Main Methods:

• Case-control study comparing type-2 diabetes patients with familial hypertriglyceridemia (cases) against controls.
• Controls were matched for age, gender, diabetes duration, treatment, and cardiovascular risk factors.
• Carotid artery intima-media thickness and exercise treadmill testing were used to assess atherosclerosis.

Main Results:

• Carotid artery intima-media thickness was significantly lower in patients with familial hypertriglyceridemia compared to normolipidemic and hyperlipidemic controls.
• Abnormalities on exercise treadmill testing were observed in similar proportions of cases and controls.
• No significant difference in the incidence of cardiovascular complications was found between the groups.

Conclusions:

• Severe hypertriglyceridemia due to familial hypertriglyceridemia is not associated with an increased prevalence of symptomatic atherosclerosis in type-2 diabetes patients.
• These findings suggest that familial hypertriglyceridemia may not confer the same cardiovascular risk as other forms of hypertriglyceridemia in this population.
• Further research is warranted to understand the specific mechanisms underlying cardiovascular risk in diabetic patients with varying lipid profiles.